MGX - Metagenomi, Inc. Common Stock Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

MGX

METAGENOMI, INC. COMMON STOCK

NASDAQ

$1.19

▼ DOWN 1.65% (-0.02)

KEY STATISTICS

Market Cap$44.80 M

52w High$3.95

52w Low$1.13

Dividend Yield—

Frequency—

P/E-0.48

Volume78.03K

Shares Out.37.65M

COMPANY

LEADERSHIP

Jian Irish

CHIEF EXECUTIVE

Jian Irish

COMPENSATION 2026

Salary$570,655

Stock Awards$427,960

Incentive Plan Pay$252,590

All Other Comp.$13,933

Total$1,667,920

ABOUT

SECTOR

Healthcare

WENT PUBLIC

February 9, 2024

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

113

PRICE TARGET

Target High$22.00

Target Low$7.00

Target Median$14.50

Target Consensus$14.50

UPCOMING EARNINGS

DateNov 10, 2026

DayTuesday

Rev. Est.$2.58M

NOV

10

TUE

PRICE

$1.19 ▼ DOWN 1.65% (−$0.02)

About Metagenomi, Inc. Common Stock

https://www.metagenomi.co ↗

Metagenomi, Inc. is a California-based gene editing biotech developing therapeutics using metagenomics-derived tools, with collaborations with Moderna, Affini-T, and Ionis for in vivo therapies and cancer treatments.

INDUSTRY

Biotechnology

A SERVICE METAGENOMI, INC. COMMON STOCK IS KNOWN FOR

MGX-001

MGX-001 is Metagenomi's lead preclinical gene-editing therapy aimed at providing a one-time, curative treatment for Hemophilia A in both children and adults.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q1-2025	Q2-2025	Q3-2025
	Operating Segments	$4.13M	$8.51M ▲	$8.66M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING

12

LISTED HERE

2

RANKED BY POSITION SIZE

0.00% · 741.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED

17.22%

HOLDERS

75

TOP 12 OF 75 · RANKED BY POSITION SIZE

Vanguard Group Inc

1.3M sh · $2.06M

Renaissance Technologies LLC

787.9K sh · $1.06M

Sozo Ventures Gp Ii, L.P.

581.6K sh · $1.33M

Catalio Capital Management, LP

529.0K sh · $856.97K

Peapod Lane Capital LLC

516.8K sh · $682.91K

Two Sigma Investments, LP

496.8K sh · $665.67K

Jane Street Group, LLC

433.9K sh · $702.85K

420.2K sh · $1.71M

Bridgeway Capital Management, LLC

395.8K sh · $530.37K

Jacobs Levy Equity Management, Inc

382.2K sh · $512.09K

Geode Capital Management, LLC

358.2K sh · $480.16K

Millennium Management LLC

310.7K sh · $736.34K

RATINGS SNAPSHOT

Overall rating: C

Discounted Cash Flow1

Return On Equity1

Return On Assets1

Debt To Equity2

Price To Earnings1

Price To Book5

Overall Score2

INSIDER TRADES

★

DIRECTOR

Eckhardt Juergen

Purchase · 21.0K shares

2026-06-09

★

DIRECTOR

Reid Laurence

Purchase · 17.4K shares

2026-06-09

★

DIRECTOR

Dere Willard H

Purchase · 21.0K shares

2026-06-09

★

DIRECTOR

BJERKHOLT ERIC

Purchase · 21.0K shares

2026-06-09

MOST RECENT ANALYST GRADES

GRADE SUMMARY

OVERWEIGHT 1

BUY 1

2 GRADES IN THE LAST 12 MONTHS

Wells Fargo OVERWEIGHT

Chardan Capital BUY

SECTORS PEERS

PEER	PRICE
ARTV	$11.09	COMPARE
IFRX	$2.23	COMPARE
ALXO	$2.00	COMPARE
STRO	$20.45	COMPARE
CNTB	$2.23	COMPARE
DTIL	$7.78	COMPARE
KLRS	$4.03	COMPARE
ATYR	$0.54	COMPARE